Ivosidenib

Jun 09, 2020

Thermo Fisher Scientific to Co-develop a Global Companion Diagnostic for Low-grade Glioma with Agios Pharmaceuticals

Nov 19, 2019

CStone announces first patient dosed in the Phase I bridging registrational study of ivosidenib

Nov 11, 2019

NuProbe Launches Ultrasensitive Sanger Assays for Oncology Therapy Selection and Recurrence Monitoring

Oct 22, 2019

Clinical Trials for Acute Myeloid Leukemia (AML) Drug Therapy Advancing With Encouraging Results

Oct 21, 2019

Acute Myeloid Leukemia Market Expected to Reach $2.2 Billion Dollars By 2025

Jul 22, 2019

CStone receives approval in China to initiate ivosidenib Phase I bridging registrational study for the treatment of IDH1 mutant relapsed or refractory AML

Jun 02, 2019

CStone submits new drug application for TIBSOVO(R) in Taiwan for the treatment of relapsed/refractory AML

May 23, 2019

Cstone partner Agios Announces the Phase 3 ClarIDHy Trial of TIBSOVO (ivosidenib) Achieved its Primary Endpoint

Feb 18, 2019

Global Cholangiocarcinoma (CCA) Market Insights 2017-2019 & 2028 - Disease Understanding, Epidemiology, Segmentation, Management, Outlook, & Drugs Uptake

Aug 21, 2018

IDH "Encyclopedic" Research Review Debuts in Academic Journal, Cancer Cell

Jul 27, 2018

BloodCenter of Wisconsin launches breakthrough FDA cleared leukemia test

Jul 20, 2018

FDA Approval Of New Precision Medicine Therapy For Deadly Blood Cancer